What is the treatment for nerve pain caused by wearing a weighted vest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Nerve Pain from Weighted Vest Use

Immediately discontinue weighted vest use and begin physical therapy with nerve mobilization techniques, combined with first-line pharmacologic treatment using pregabalin 75 mg at bedtime, titrating to 150 mg twice daily over one week. 1, 2

Immediate Management: Remove the Offending Cause

  • Stop wearing the weighted vest immediately to eliminate ongoing nerve compression or traction injury, as continued use will perpetuate symptoms and delay recovery 3, 4
  • The nerve injury pattern from weighted vests most commonly affects the brachial plexus through shoulder strap compression/traction (rucksack palsy), presenting as paresthesias, pain, cramping, and muscle weakness in the upper extremities 3
  • Direct trauma, compression from equipment, or excessive stretching of peripheral nerves requires cessation of the causative activity as the foundation of treatment 4

First-Line Nonpharmacologic Treatment

  • Initiate physical therapy immediately focusing on nerve mobilization techniques, specifically cervical spine and brachial plexus mobilization to relieve nerve tension and reduce symptoms 1, 3
  • Apply local heat therapy to the affected shoulder/neck region for moderate pain relief, which can be combined with other modalities for additive benefit 1, 5
  • Consider transcutaneous electrical nerve stimulation (TENS) as part of a multimodal approach, though evidence is limited and it should never be used as monotherapy 1, 6

First-Line Pharmacologic Treatment

Pregabalin is the preferred first-line medication for neuropathic pain with the following dosing:

  • Start at 75 mg at bedtime on day 1 2, 7
  • Increase to 75 mg twice daily (150 mg/day total) after 3-7 days 2, 7
  • If inadequate response after 1 week, increase to 150 mg twice daily (300 mg/day total) 2, 7
  • Maximum dose is 300 mg twice daily (600 mg/day) for patients with ongoing pain who tolerate lower doses, though this carries higher discontinuation rates due to adverse effects 7

Alternative first-line option if pregabalin is unavailable or not tolerated:

  • Gabapentin starting with 600 mg on day 1, increasing every 3 days to 1800 mg divided in 3 doses (typical effective range 1800-3600 mg/day) 2

Second-Line Pharmacologic Treatment

If gabapentinoids fail or are contraindicated after 3-4 weeks at therapeutic doses:

  • Tricyclic antidepressants: Nortriptyline or desipramine 10-25 mg at bedtime, titrating slowly to maximum <100 mg/day to minimize anticholinergic effects 1, 2
  • SNRIs: Duloxetine 30 mg daily, titrating to 60 mg daily if needed 1, 5
  • Topical therapies: Lidocaine patches or cream applied directly to painful areas, which has stronger evidence than topical amitriptyline or ketamine 1

Combination Therapy for Refractory Pain

  • If monotherapy provides inadequate relief (pain ≥4/10 after 3-4 months at therapeutic doses), combine pregabalin with a tricyclic antidepressant (nortriptyline) for additive benefit 2
  • NSAIDs (naproxen, ibuprofen) can be added for any concurrent myofascial pain component 1, 5

Interventional Procedures for Refractory Cases

If pain persists despite optimal pharmacologic management:

  • Refer to pain management specialist for consideration of nerve blocks (intercostal or periorbital depending on affected nerve distribution) using corticosteroid with long-acting sodium channel blocker 1
  • Dorsal column stimulation may be considered for severe refractory neuropathic pain, though data are limited 1

Critical Pitfalls to Avoid

  • Never continue weighted vest use even with modifications, as ongoing compression/traction will prevent nerve recovery 3, 4
  • Avoid opioids as first or second-line therapy due to lack of long-term efficacy data for neuropathic pain and significant harm potential including addiction 1, 2
  • Do not use SSRIs (paroxetine, fluoxetine, citalopram) as they have inconsistent evidence for neuropathic pain 2
  • Set realistic expectations: Neuromodulators require 3-4 months at therapeutic doses to achieve maximum pain reduction; patients must continue treatment even without immediate relief 1
  • Screen for psychological comorbidities: Chronic neuropathic pain commonly presents with anxiety and depression requiring concurrent mental health support through cognitive behavioral therapy or referral to mental health specialists 1

Prevention of Recurrence

If weighted vest use is resumed after complete symptom resolution:

  • Use wider, better-padded shoulder straps with proper adjustment to distribute load 3
  • Incorporate hip belt to reduce shoulder strap pressure 3
  • Reduce total vest weight and duration of wear 3
  • Strengthen shoulder girdle muscles through resistance training before resuming vest use 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Alternative Medications for Neuropathy After Duloxetine Intolerance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Load Carriage-Related Paresthesias: Part 1: Rucksack Palsy and Digitalgia Paresthetica.

Journal of special operations medicine : a peer reviewed journal for SOF medical professionals, 2016

Guideline

Treatment of Chronic Myofascial Back Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

TENS for Chronic Low Back Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.